alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 63, Number 150 (Wednesday, August 5, 1998)]
[Proposed Rules]
[Page 41743]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-20934]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Parts 65, 66, and 147

[Docket No. 27863; Notice No. 98-5]
RIN 2120-AF22


Revision of Certification Requirements: Mechanics and Repairmen; 
Correction

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of Proposed Rulemaking (NPRM); correction.

-----------------------------------------------------------------------

SUMMARY: This document corrects the preamble to a proposed rule 
published in the Federal Register on July 9, 1998, (63 FR 37172) that 
would revise the certification requirements for mechanics and 
repairmen. This correction provides the public with the correct 
telephone number to obtain a copy of the NPRM.

FOR FURTHER INFORMATION CONTACT:
Leslie K. Vipond, AFS-350, Continuous Airworthiness Maintenance 
Division, Flight Standards Service, Federal Aviation Administration, 
800 Independence Avenue SW., Washington DC 20591, telephone: (202) 267-
3269.

Correction

    In proposed rule FR Doc. 98-17589 beginning on page 37172 in the 
Federal Register issue of Thursday, July 9, 1998, make the following 
correction:
    On page 37172, in the Availability of NPRMs section, in the third 
column, in the second complete paragraph, on line 7, the telephone 
number specified to obtain a copy of the NPRM is listed as ``(202) 267-
9860.'' This should be changed to read ``(202) 267-9680.''

    Issued: in Washington, DC on July 31, 1998.
Donald P. Byrne,
Assistant Chief Counsel, Regulations Division.
[FR Doc. 98-20934 Filed 8-4-98; 8:45 am]
BILLING CODE 4910-13-M
exhibit_4-10.htm










EXHIBIT 4.10







Summary – Directors Compensation


 


General


 


The following table sets forth all cash and cash-equivalent compensation we paid with respect to all of our non-employee directors as a group for the periods indicated:


 



	  	 	
Salaries, fees,



commissions and bonuses



	 	 	


Pension, retirement



and similar benefits



	 
	
All non-employee directors


 as a group, consisting of 5 persons*


for the year ended December 31, 2011

	 	$	64,000	 	 	 	--	 





 


* Excluding Shimon Alon, our Chairman Chief Executive Officer. For details, see Item 6B of the annual report.


 


In accordance with the approval of our shareholders, non-employee directors who are not outside directors receive an annual fee of $9,000 and an attendance fee of $300 per meeting attended. Our non-employee outside directors receive, effective July 2008, an annual fee of $9,000 (equivalent to approximately NIS 32,000) and an attendance fee of NIS 1,674 (equivalent to approximately $470) per meeting attended, both linked to the Israeli Consumer Price Index, or CPI.


 


In November 2011, our Audit Committee and Board of Directors adopted a revised stock option policy for non-employee directors, which policy was subsequently approved by our shareholders. According to the stock option policy, each of our non-employee directors who may serve from time to time, including our outside directors, will be granted options, as follows:


 



	
  

	
·

	
a grant of options under our stock option plans to purchase 80,000 ordinary shares, which vest in three equal installments over three years;







 



	
  

	
·

	
the exercise price of all options will be equal to the fair market value of the ordinary shares on the date of the grant (i.e., the closing price of our shares on the date of the annual general meeting of shareholders in which such director is elected or reelected); and







 



	
  

	
·

	
the portion of outstanding options scheduled to vest during any year in which the director’s service with us is terminated or expires will accelerate and become fully vested and exercisable for a period of 180 days thereafter, unless termination was due to the director’s resignation or for one of the causes set forth in the Companies Law.







 


Other than the foregoing fees, reimbursement for expenses and the award of stock options, we do not compensate our directors for serving on our board of directors.
APP A 

DSCPH 4155.2 

 *********************** 

 * MONOGRAPH No. M1F 

 *********************** 

ITEM: Unit Basic Load (Pallet), MRE 

NSN: NA ITEM SPECIFICATION: DSCP FORM 3507 and Assembly Document (ACR-M-026) 

APPROXIMATE CALORIC VALUE: Not applicable. 

 

CHARACTERISTICS OF ITEM: 

There are 48 cases of MREs on each pallet. Each pallet will have 24 “A” cases and 24 “B” cases. At 

least two boxes in each tier will be oriented to display the TTI label. The pallet load has a fiberboard 

cap. 

For MREs packed prior to May 2006, there should be 3 straps on one side (the width side) and 2 

straps on the other side (the length side). Beginning in May 2006, the pallet has three straps on the 

width side, but none on the length side. In addition, a requirement for stretch wrap aound the entire 

pallet was added. 

 

DEFECTS LIKELY TO OCCUR: Torn stretch wrap may hinder the ability of the wrap to hold the 

pallet load together. Moldy cases may occur if moisture or condensation is unable to evaporate from 

under the shrink wrap. Pallets may have broken boards or stringers. Case straps may be broken. 

UNIQUE EXAMINATION/TEST PROCEDURES: None 

SPECIAL NOTES: None.
DRAFT – July 21, 2009 

MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP) 

Centers for Disease Control and Prevention
 

1600 Clifton Road, NE, Tom Harkin Global Communications Center (Building 19), Atlanta, Georgia
 

Wednesday July 29, 2009
 

8:00	 Welcome & Introductions 

Dr. Dale Morse (Chair, ACIP), Dr. Larry Pickering (Executive Secretary, ACIP; CDC) 

8:15	 Introduction and goals of the meeting 

Dr. Kathy Neuzil (ACIP Influenza Work Group Chair) 

8:30	 Novel influenza A(H1N1) epidemiology in the United States 

Dr. Anthony Fiore (CDC/CCID/NCIRD/ID; ACIP Influenza Work Group Lead) 

9:15	 Novel influenza A(H1N1) epidemiology – global update 

Dr. Anthony Fiore 

9:30	 Virology and immunology update 

Dr. Alexander Klimov (CDC/CCID/NCIRD/ID) 

10:00	 Vaccine development and formulations 

Dr. Robin Robinson (BARDA) 

10:15	 FDA/VRBPAC update 

Dr. Wellington Sun (FDA) 

10:30	 coffee break 

10:45	 Implementation planning 

Dr. Pascale Wortley (CDC/CCID/NCIRD/ISD) 

11:30	 Communications strategy 

Dr. Kris Sheedy (CDC/CCHIS/NCHM), Associate Director for Communication Science) 

11:50	 Public Comment 

12:00	 lunch 

1:00	 ACIP Influenza Work Group recommendations 

Dr. Anthony Fiore (CDC/CCID/NCIRD/ID; ACIP Influenza Work Group Lead) 

Dr. Kathy Neuzil (ACIP Influenza Work Group Chair) 

3:00	 Adjourn 

Page 1 of 2 
 

Biomedical Advanced Research and Development Authority (of HHS) 

 Coordinating Center for Health information and Service 

 Coordinating Center for Infectious Diseases 

 Council of State and Territorial Epidemiologists 

 Food and Drug Administration (of HHS) 

Department of Health and Human Services 

 Influenza Division 

 Immunization Services Division 

 National Center for Health Marketing 

 National Center for Immunization and Respiratory Diseases 

 To Be Determined 

 

 

 

DRAFT – July 21, 2009 

Acronyms 

ASTHO Association of State and Territorial Health Officers 

BARDA 

CCHIS 

CCID 

CSTE 

FDA 

HHSU.S.

ID 

ISD 

NACCHO National Association of County and City Health Officials 

NCHM 

NCIRD 

TBD

VRBPAC Vaccines and Related Biological Products Advisory Committee 

This document can be found on the cdc website at: 

http://www.cdc.gov/vaccines/recs/acip/downloads/agenda-jul09.rtf 

Page 2 of 2
<TABLE> <S> <C>

<ARTICLE>                                        9
<MULTIPLIER>                                 1,000



<S>                                        <C>
<PERIOD-TYPE>                                3-MOS
<FISCAL-YEAR-END>                      DEC-31-1999
<PERIOD-START>                          JUL-1-1999
<PERIOD-END>                           SEP-30-1999
<CASH>                                      14,771
<INT-BEARING-DEPOSITS>                           0
<FED-FUNDS-SOLD>                            11,830
<TRADING-ASSETS>                                 0
<INVESTMENTS-HELD-FOR-SALE>                 95,308
<INVESTMENTS-CARRYING>                      34,907
<INVESTMENTS-MARKET>                        34,316
<LOANS>                                    234,556
<ALLOWANCE>                                  3,916
<TOTAL-ASSETS>                             406,876
<DEPOSITS>                                 297,677
<SHORT-TERM>                                 4,120
<LIABILITIES-OTHER>                          2,416
<LONG-TERM>                                 70,000
<COMMON>                                     2,158
<PREFERRED-MANDATORY>                            0
<PREFERRED>                                      0
<OTHER-SE>                                  30,505
<TOTAL-LIABILITIES-AND-EQUITY>             406,876
<INTEREST-LOAN>                              5,622
<INTEREST-INVEST>                            2,033
<INTEREST-OTHER>                               118
<INTEREST-TOTAL>                             7,773
<INTEREST-DEPOSIT>                           3,503
<INTEREST-EXPENSE>                           4,328
<INTEREST-INCOME-NET>                        3,445
<LOAN-LOSSES>                                  415
<SECURITIES-GAINS>                               0
<EXPENSE-OTHER>                              2,632
<INCOME-PRETAX>                              1,339
<INCOME-PRE-EXTRAORDINARY>                   1,339
<EXTRAORDINARY>                                  0
<CHANGES>                                        0
<NET-INCOME>                                   984
<EPS-BASIC>                                  .23
<EPS-DILUTED>                                  .23
<YIELD-ACTUAL>                                3.94
<LOANS-NON>                                    931
<LOANS-PAST>                                   330
<LOANS-TROUBLED>                                 0
<LOANS-PROBLEM>                                  0
<ALLOWANCE-OPEN>                             3,564
<CHARGE-OFFS>                                  729
<RECOVERIES>                                   277
<ALLOWANCE-CLOSE>                            3,916
<ALLOWANCE-DOMESTIC>                         3,916
<ALLOWANCE-FOREIGN>                              0
<ALLOWANCE-UNALLOCATED>                        300





</TABLE>
---

|CERTIFICATION OF                                         
|---------------------------------------------------------
|CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL
      OFFICER
|PURSUANT TO                                              
|18 U.S.C. SECTION 1350,                                  
|AS ADOPTED PURSUANT TO                                   
|SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002            

I, John P. Thornton, the Chief Executive Officer and Chief
Financial Officer of NorPac Technologies, Inc. (the Company), hereby certify
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

| | (i)  | the Quarterly Report on Form 10-QSB of the Company, for
      the fiscal quarter ended March 31, 2007, and to which this certification
      is attached as Exhibit 32.1 (the Report) fully complies with the
      requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
      1934, as amended; and
| | ---- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |      |                                                                                                                                                                                                                                                                                                                           
| | (ii) | the information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.                                                                                                                                                          

| | By:    | /s/
      John P. Thornton       
| | ------ | ---------------------------------
| | Name:  | JOHN P. THORNTON                 
| |        |                                  
| | Title: | Chief Executive Officer and Chief
| |        | Financial
  Officer              
| |        |                                  
| | Date:  | May 14, 2007                     

A signed original of this written statement required by
Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company
and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.

This certification accompanies the Form 10-QSB to which it
relates, is not deemed filed with the Securities and Exchange Commission and is
not to be incorporated by reference into any filing of the Company under the
Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made
before or after the date of the Form 10-QSB), irrespective of any general
incorporation language contained in such filing.

---
cc: Hon. Michelle Leavitt, District Judge Willie James Smith, Jr. Attorney GeneraVCarson City Clark County District Attorney Eighth District Court Clerk

SUPREME COURT

OF NEVADA 2 (0) 1947A
No. 11-265.

#### William Hart, II, Petitioner v. United States.

565 U.S. 1111, 132 S. Ct. 1001,

181 L. Ed. 2d 733,

2012 U.S. LEXIS 406.

January 9, 2012.

Petition for writ of certiorari to the United States Court of Appeals for the Sixth Circuit denied.

*734Same case below, 635 F.3d 850.
ID Descriptor L* a* b* c h dL* da* db* dEcmc*

Standard 18207 STANDARD 82.03 2.70 70.14

Tolerance

1

2

3

4

5

6

7

8

9

Shade Number YELLOW 3511 Piece/Roll Number 18207

DLA/NAVY SHADE TOLERANCE PROJECT October 29, 2018

Fabric Nomenclature CLOTH, TWILL, POLYESTER AND COTTON NCTRF PD 01-11

COMMENTS: NUMBERS ARE FOR REFERENCE ONLY 

Equipment Type HUNTER ULTRA SCAN PRO Setting Mode: Specular Included - Reflectance

UV Filter – OUT UV Lamp OFF
No. 11-7230.

#### James Garrett Freeman, Petitioner v. Texas.

565 U.S. 1161, 132 S. Ct. 1099,

181 L. Ed. 2d 986,

2012 U.S. LEXIS 834.

January 17, 2012.

Petition for writ of certiorari to the Court of Criminal Appeals of Texas denied.

Same case below, 340 S.W.3d 717.
[Federal Register Volume 74, Number 37 (Thursday, February 26, 2009)]
[Notices]
[Page 8788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-4084]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER09-705-000]


Saracen Power LLC; Supplemental Notice That Initial Market-Based 
Rate Filing Includes Request for Blanket Section 204 Authorization

February 19, 2008.
    This is a supplemental notice in the above-referenced proceeding of 
Saracen Power LLC's application for market-based rate authority, with 
an accompanying rate tariff, noting that such application includes a 
request for blanket authorization, under 18 CFR part 34, of future 
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the 
Federal Energy Regulatory Commission, 888 First Street, NE., 
Washington, DC 20426, in accordance with Rules 211 and 214 of the 
Commission's Rules of Practice and Procedure (18 CFR 385.211 and 
385.214). Anyone filing a motion to intervene or protest must serve a 
copy of that document on the Applicant.
    Notice is hereby given that the deadline for filing protests with 
regard to the applicant's request for blanket authorization, under 18 
CFR part 34, of future issuances of securities and assumptions of 
liability, is March 11, 2009.
    The Commission encourages electronic submission of protests and 
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet 
access who will eFile a document and/or be listed as a contact for an 
intervenor must create and validate an eRegistration account using the 
eRegistration link. Select the eFiling link to log on and submit the 
intervention or protests.
    Persons unable to file electronically should submit an original and 
14 copies of the intervention or protest to the Federal Energy 
Regulatory Commission, 888 First St., NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in 
the Commission's eLibrary system by clicking on the appropriate link in 
the above list. They are also available for review in the Commission's 
Public Reference Room in Washington, DC. There is an eSubscription link 
on the Web site that enables subscribers to receive e-mail notification 
when a document is added to a subscribed docket(s). For assistance with 
any FERC Online service, please e-mail <a href="/cdn-cgi/l/email-protection#f7b1b2a5b4b8999b9e9992a4828787988583b791928594d9909881"><span class="__cf_email__" data-cfemail="8dcbc8dfcec2e3e1e4e3e8def8fdfde2fff9cdebe8ffeea3eae2fb">[email protected]</span></a> or 
call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-4084 Filed 2-25-09; 8:45 am]
BILLING CODE 6717-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
24 January 2013 *********************************

NSN: 8960-01-613-1436 (BPO) *MONOGRAPH NO: MCW/LRP 46

*********************************

Item: Beverage powder, Carbohydrate, Orange, Fortified with ascorbic acid, vitamin D, and 

fiber, and enhanced with maltodextrin (Flavor 4, Formulation c)

Document: PCR-B-055, Beverage Powder, Carbohydrate, Packaged in a Flexible Pouch, Shelf 

Stable

Approximate Caloric Value Per Serving: 180 Component Classification: Secondary

Estimated Shelf Life: 36 months at 80°F

Item Characteristics

Appearance: Powdered product: Uniformly blended, free flowing, homogenous, dry mixture.

Rehydrated product: Clear to slightly cloudy, sediment-free, bright orange color liquid.

Odor: Powdered product: Typical of flavor specified.

Rehydrated product: Sweet, sour, distinct orange.

Flavor: Powdered product: Typical of flavor specified.

Rehydrated product: Sweet, sour, distinct orange.

Texture: Powdered product: Free of hard lumps.

Possible Deteriorative Changes 

Appearance: Powdered product: Lumpy or caked, not free flowing. 

Rehydrated product: Darkened color, settling or undissolved material.

Odor: Perfume, not orange, oxidized vitamins.

Flavor: Perfume, lack of orange flavor, lack of sweetness, extreme bitterness or sourness, 

oxidized and or excessively strong vitamin flavor.

Texture: Settling or undissolved material when rehydrated, produces an astringent mouth feel.

Unique Examination/Test Procedures

Initial exam shall be done in the dry state. For final exam, prepare beverage in accordance with package 

directions. Check package seal integrity for poor seals due to improper sealing or product in seal area.
24 January 2013 *********************************

NSN: 8960-01-613-1436 (BPO) *MONOGRAPH NO: MCW/LRP 46

*********************************

Special Notes

Service is significantly affected if the powder is caked. Caking is an indication of high moisture levels, 

absence of anticaking ingredient and/or extremely high storage temperatures, i.e., over 125°F for more 

than one month.
```

[Federal Register Volume 74, Number 37 (Thursday, February 26, 2009)]
[Notices]
[Page 8812]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-4027]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--PXI Systems Alliance, Inc.

    Notice is hereby given that, on January 21, 2009, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), PXI Systems Alliance, Inc. 
has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing changes in its 
membership. The notifications were filed for the purpose of extending 
the Act's provisions limiting the recovery of antitrust plaintiffs to 
actual damages under specified circumstances. Specifically, Tabor 
Electronics Ltd.acher, Tel Hanan, Israel; Corelis, Inc., Cerritos, CA; 
C&H Technologies, Round Rock, TX; Elma Electronic Inc., Fremont, CA; 
and SP Devices AB, Linkoping, Sweden have been added as parties to this 
venture. Also, Viewpoint Systems Inc. Rochester, NY has withdrawn as a 
party to this venture. The following members have changed their names: 
TZ Mikroelektronik to Eberspacher Electronics GmbH & Co., KG, 
Goppingen, Germany; and Spectrum GmbH to Spectrum Systemtwicklung 
Microelectronic GmbH, Grosshansdorf, Germany.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and PXI Systems Alliance, Inc. intends 
to file additional written notifications disclosing all changes in 
membership.
    On November 22, 2000, PXI Systems Alliance, Inc. filed its original 
notification pursuant to Section 6(a) of the Act. The Department of 
Justice published a notice in the Federal Register pursuant to Section 
6(b) of the Act on March 8, 2001 (66 FR 13971).
    The last notification was filed with the Department on November 3, 
2008. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on December 12, 2008 (73 FR 75772).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. E9-4027 Filed 2-25-09; 8:45 am]
BILLING CODE 4410-11-M
```
No. D-2618.

#### In the Matter of Discipline of John Joseph Zodrow.

565 U.S. 1107, 132 S. Ct. 1086,

181 L. Ed. 2d 804,

2012 U.S. LEXIS 561.

January 9, 2012.

John Joseph Zodrow, of Denver, Colorado, is suspended from the practice of law in this Court and a rule will issue, returnable within 40 days, requiring him to show cause why he should not be disbarred from the practice of law in this Court.
No. 11-7091.

#### In re Edward Mierzwa, Petitioner.

565 U.S. 1109, 132 S. Ct. 1026,

181 L. Ed. 2d 794,

2012 U.S. LEXIS 565.

January 9, 2012.

Motion of petitioner for leave to proceed in forma pauperis denied, and petition for writ of mandamus dismissed. See Rule 39.8.
No. 11-604.

#### EM Ltd., et al., Petitioners v. Republic of Argentina, et al.

565 U.S. 1154, 132 S. Ct. 1133,

181 L. Ed. 2d 974,

2012 U.S. LEXIS 875.

January 17, 2012.

The Solicitor General is invited to file a brief in this case expressing the views of the United States.

Justice Sotomayor took no part in the consideration or decision of this petition.

Same case below, 652 F.3d 172, 414 Fed. Appx. 514.